Clinical Genomics

The national Clinical Genomics platform was established to facilitate the translation of new high-throughput (HTP) techniques, such as next-generation sequencing (NGS), into clinical use. The overall aim of the platform is to meet the needs from translational researchers and clinicians in healthcare and public health systems by providing service and support at the national level in order to promote and adapt the use of HTP techniques in routine diagnostics.

  • Bridging Translational Research and Routine Diagnostics: The platform comprises seven Clinical Genomics nodes, located strategically at Swedish universities with medical faculties: Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala, and Örebro. These nodes serve as vital centers for advancing HTP technologies in clinical diagnostics.
  • Harnessing HTP Technologies for Precision Medicine: HTP technologies hold promise in clinical diagnostics for cancer, inherited, and communicable diseases, generating vast patient data. Yet, challenges include complex workflows, specialized equipment, and extensive data analysis. Clinical Genomics integrates expertise for secure data management, processing, and accurate test interpretation, aligning with healthcare standards.
  • Fostering National Competence for Healthcare Innovation: A primary goal of the platform is to function as a national competence center for HTP analyses, while collaboratind with healthcare institutions nationwide. Clinical Genomics aims to disseminate current information on updated protocols, guidelines and ethical standards for interpreting test results using these advanced technologies.

For services and detailed information

Last updated: 2024-05-13

Content Responsible: Eva Berglund(eva.berglund@scilifelab.uu.se)